Nadia Michel Nasser

Title: Nadia Michel Nasser: Innovator in GPR84 Antagonists

Introduction

Nadia Michel Nasser is a prominent inventor based in Laval, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target GPR84-mediated disorders. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Nadia holds a patent for "GPR84 antagonists and uses thereof." This invention provides compounds and compositions that inhibit GPR84, offering potential treatments for various disorders associated with this receptor. The patent highlights her commitment to addressing critical health issues through scientific innovation. She has 1 patent to her name.

Career Highlights

Nadia is currently associated with Liminal Biosciences Limited, where she continues to push the boundaries of research and development. Her role at the company allows her to collaborate with other experts in the field, further enhancing her contributions to biochemistry and pharmacology.

Collaborations

One of her notable collaborators is Mylène De Léséleuc, who works alongside Nadia in their research endeavors. Together, they aim to explore new avenues in the treatment of GPR84-mediated disorders, leveraging their combined expertise to drive innovation.

Conclusion

Nadia Michel Nasser is a trailblazer in the field of GPR84 antagonists, with a focus on developing effective treatments for related disorders. Her work exemplifies the impact of innovative thinking in the medical field, and her contributions are sure to influence future research and development.